Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.

Ding, Ling; Yang, Yuning; Lu, Qin; Cao, Zhiyun; Weygant, Nathaniel

Ding, Ling; Yang, Yuning; Lu, Qin; Cao, Zhiyun; Weygant, Nathaniel.

Affiliation

Ding L; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, CN 350122, China.
Yang Y; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, CN 350122, China.
Lu Q; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, CN 350122, China.
Cao Z; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, CN 350122, China.
Weygant N; Key Laboratory of Integrative Medicine, Fujian Province University, Fuzhou, Fujian, CN 350122, China.

Curr Cancer Drug Targets ; 22(3): 195-208, 2022.

Article in En | MEDLINE | ID: mdl-35078398

Subject(s)

Colorectal Neoplasms; Organoids; Cell Proliferation; Colorectal Neoplasms/drug therapy; Colorectal Neoplasms/pathology; Humans; Neoplastic Stem Cells/pathology; Organoids/pathology; Precision Medicine; Tumor Microenvironment

Key words

Colorectal cancer; LGR5; cancer stem cells; patient-derived organoids; personalized medicine; tumor microenvironment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Organoids Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Cancer Drug Targets Journal subject: ANTINEOPLASICOS / NEOPLASIAS Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google